These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 10954004

  • 1. Dihydropyridine calcium antagonists and renal function in hypertensive kidney transplant recipients.
    Rump LC, Oberhauser V, Schwertfeger E, Speidel L, Zimmerhackl L, Kirste G, Grotz W.
    J Hypertens; 2000 Aug; 18(8):1115-9. PubMed ID: 10954004
    [Abstract] [Full Text] [Related]

  • 2. Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study.
    Kuypers DR, Neumayer HH, Fritsche L, Budde K, Rodicio JL, Vanrenterghem Y, Lacidipine Study Group.
    Transplantation; 2004 Oct 27; 78(8):1204-11. PubMed ID: 15502721
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B, Kobelt V, Erfmann M, Hausberg M, Gerhardt U, Rahn KH, Hohage H.
    Transpl Int; 2003 May 27; 16(5):313-20. PubMed ID: 12759722
    [Abstract] [Full Text] [Related]

  • 4. Renal functional reserve in calcium channel blocker-treated hypertensive recipients of kidney transplant.
    Tack I, Rostaing L, Tran-Van T, Lloveras JJ, Durand D, Suc JM, Ader JL.
    Nephrol Dial Transplant; 1995 May 27; 10 Suppl 6():117-9. PubMed ID: 8524480
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A multicenter, randomized, double-blind, placebo-controlled, two-year trial to study the effect of nitrendipine on chronic renal transplant function.
    Barenbrock M, Colmorgen U, Firschka E, Gellert J, Lippert J, Schröder K, Spieker C, Voigt-Ladner G, Wagner K, Neumayer HH.
    Clin Nephrol; 1995 Jun 27; 43(6):388-91. PubMed ID: 7554523
    [Abstract] [Full Text] [Related]

  • 7. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR.
    Drugs; 2005 Jun 27; 65 Suppl 2():29-39. PubMed ID: 16398060
    [Abstract] [Full Text] [Related]

  • 8. Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors.
    Grekas D, Dioudis C, Kalevrosoglou I, Alivanis P, Derveniotis V, Tourkantonis A.
    Kidney Int Suppl; 1996 Jun 27; 55():S97-100. PubMed ID: 8743523
    [Abstract] [Full Text] [Related]

  • 9. Divergent effects of calcium channel and angiotensin converting enzyme blockade on glomerulotubular function in cyclosporine-treated renal allograft recipients.
    Sennesael JJ, Lamote JG, Violet I, Tasse S, Verbeelen DL.
    Am J Kidney Dis; 1996 May 27; 27(5):701-8. PubMed ID: 8629631
    [Abstract] [Full Text] [Related]

  • 10. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
    Rodicio JL.
    Blood Press Suppl; 1996 May 27; 5():10-5. PubMed ID: 8973787
    [Abstract] [Full Text] [Related]

  • 11. Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients.
    Bunke M, Ganzel B.
    J Heart Lung Transplant; 1992 May 27; 11(6):1194-9. PubMed ID: 1457446
    [Abstract] [Full Text] [Related]

  • 12. Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study.
    Midtvedt K, Ihlen H, Hartmann A, Bryde P, Bjerkely BL, Foss A, Fauchald P, Holdaas H.
    Transplantation; 2001 Jul 15; 72(1):107-11. PubMed ID: 11468543
    [Abstract] [Full Text] [Related]

  • 13. Renal and haemodynamic effects of amlodipine and nifedipine in hypertensive renal transplant recipients.
    Venkat-Raman G, Feehally J, Elliott HL, Griffin P, Moore RJ, Olubodun JO, Wilkinson R.
    Nephrol Dial Transplant; 1998 Oct 15; 13(10):2612-6. PubMed ID: 9794569
    [Abstract] [Full Text] [Related]

  • 14. Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril.
    Midtvedt K, Hartmann A, Foss A, Fauchald P, Nordal KP, Rootwelt K, Holdaas H.
    Transplantation; 2001 Dec 15; 72(11):1787-92. PubMed ID: 11740389
    [Abstract] [Full Text] [Related]

  • 15. The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation.
    Madsen JK, Sørensen SS, Hansen HE, Pedersen EB.
    Nephrol Dial Transplant; 1998 Sep 15; 13(9):2327-34. PubMed ID: 9761517
    [Abstract] [Full Text] [Related]

  • 16. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y, Hayashi M, Kawamura T, Shiigai T, Tomino Y, Yamada K, Kitajima T, Ideura T, Koyama A, Sugisaki T, Suzuki H, Umemura S, Kawaguchi Y, Uchida S, Kuwahara M, Yamazaki T, Japanese Lasartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) Study Investigators.
    Clin Exp Nephrol; 2003 Sep 15; 7(3):221-30. PubMed ID: 14586719
    [Abstract] [Full Text] [Related]

  • 17. Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants.
    Mourad G, Ribstein J, Mimran A.
    Kidney Int; 1993 Feb 15; 43(2):419-25. PubMed ID: 8382753
    [Abstract] [Full Text] [Related]

  • 18. Elevated urinary angiotensinogen a marker of intrarenal renin angiotensin system in hypertensive renal transplant recipients: does it play a role in development of proteinuria in hypertensive renal transplant patients?
    Aybal Kutlugun A, Altun B, Buyukasik Y, Aki T, Turkmen E, Altindal M, Yildirim T, Yilmaz R, Turgan C.
    Transpl Int; 2012 Jan 15; 25(1):13-8. PubMed ID: 21923802
    [Abstract] [Full Text] [Related]

  • 19. Anti-proteinuric effect of an N-type calcium channel blocker, cilnidipine.
    Tsuchihashi T, Ueno M, Tominaga M, Kajioka T, Onaka U, Eto K, Goto K.
    Clin Exp Hypertens; 2005 Nov 15; 27(8):583-91. PubMed ID: 16303635
    [Abstract] [Full Text] [Related]

  • 20. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR, Shand BI, Smith AH, Robson RA, Lynn KL.
    Clin Nephrol; 1997 Oct 15; 48(4):224-9. PubMed ID: 9352156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.